- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Lauren Harner Suggests 2 Solutions That Address Primary Medication Nonadherence
There are 2 strategies for addressing primary medication nonadherence that have seen success, according to Lauren Harner, JD, senior manager for policy at PhRMA.
The 2 strategies for addressing primary medication nonadherence that have seen success are medication synchronization and comprehensive medication management, according to Lauren Harner, JD, senior manager for policy at PhRMA.
The success of these strategies hinge on the concepts of convenience for the patient and better involvement from the pharmacist and the provider, she explained.
“I think that if the patient really understands the impact of the drug or the treatment on their condition, I think they’re more likely to want to start their medication regime,” Harner says. “So I think those are 2 potential solutions.”
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Real-World Discontinuations of Ocrelizumab in MS Comparable to Pivotal Trials
January 9th 2025Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in pivotal clinical trials among patients with different types of multiple sclerosis (MS).
Read More
